The immune mechanisms of acute exacerbations of idiopathic pulmonary fibrosis

被引:0
|
作者
Chen, Tao [1 ]
Sun, Wei [2 ]
Xu, Zuo-jun [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China
[2] Tianjin Med Univ, Hosp 2, Dept Resp & Crit Med, Tianjin, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
基金
中国国家自然科学基金;
关键词
acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF); immune mechanism; macrophages; Th17; acute lung injury; COLONY-STIMULATING FACTOR; REGULATORY T-CELLS; RECEPTOR-3 L412F POLYMORPHISM; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE PROGRESSION; SUPPRESSOR-CELLS; M2; MACROPHAGES; LUNG; TRANSPLANTATION; PATHOGENESIS;
D O I
10.3389/fimmu.2024.1450688
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF) are the leading cause of mortality among patients with IPF. There is still a lack of effective treatments for AE-IPF, resulting in a hospitalization mortality rate as high as 70%-80%. To reveal the complicated mechanism of AE-IPF, more attention has been paid to its disturbed immune environment, as patients with IPF exhibit deficiencies in pathogen defense due to local immune dysregulation. During the development of AE-IPF, the classical stimulatory signals in adaptive immunity are inhibited, while the nonclassical immune reactions (Th17) are activated, attracting numerous neutrophils and monocytes to lung tissues. However, there is limited information about the specific changes in the immune response of AE-IPF. We summarized the immune mechanisms of AE-IPF in this review.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Acute Exacerbations of Idiopathic Pulmonary Fibrosis
    Antoniou, Katerina M.
    Wells, Athol U.
    RESPIRATION, 2013, 86 (04) : 265 - 274
  • [2] Acute exacerbations of idiopathic pulmonary fibrosis
    Collard, Harold R.
    Moore, Bethany B.
    Flaherty, Kevin R.
    Brown, Kevin K.
    Kaner, Robert J.
    King, Talmadge E., Jr.
    Lasky, Joseph A.
    Loyd, James E.
    Noth, Imre
    Olman, Mitchell A.
    Raghu, Ganesh
    Roman, Jesse
    Ryu, Jay H.
    Zisman, David A.
    Hunninghake, Gary W.
    Colby, Thomas V.
    Egan, Jim J.
    Hansell, David M.
    Johkoh, Takeshi
    Kaminski, Naftali
    Kim, Dong Soon
    Kondoh, Yasuhiro
    Lynch, David A.
    Mueller-Quernheim, Joachim
    Myers, Jeffrey L.
    Nicholson, Andrew G.
    Selman, Moises
    Toews, Galen B.
    Wells, Athol U.
    Martinez, Fernando J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (07) : 636 - 643
  • [3] Acute exacerbations in idiopathic pulmonary fibrosis
    Crowley, SP
    Kelly, P
    Egan, JJ
    ANNALS OF INTERNAL MEDICINE, 2006, 144 (03) : 218 - 218
  • [4] Postvaccination Acute Exacerbations of Idiopathic Pulmonary Fibrosis?
    Huang, Jin-Xian
    Wei, James Cheng-Chung
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 206 (07) : 917 - 917
  • [5] Acute exacerbations in patients with idiopathic pulmonary fibrosis
    Kim, Dong Soon
    RESPIRATORY RESEARCH, 2013, 14
  • [6] Acute exacerbations in patients with idiopathic pulmonary fibrosis
    Dong Soon Kim
    Respiratory Research, 14
  • [7] Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis
    Judge, Eoin P.
    Fabre, Aurelie
    Adamali, Huzaifa I.
    Egan, Jim J.
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40 (01) : 93 - 100
  • [8] Acute interstitial pneumonia and acute exacerbations of idiopathic pulmonary fibrosis
    Swigris, Jeffrey J.
    Brown, Kevin K.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 27 (06) : 659 - 667
  • [9] Acute exacerbations of idiopathic pulmonary fibrosis and the role of corticosteroids
    Brereton, Christopher J.
    Jo, Helen E.
    BREATHE, 2020, 16 (03) : 1 - 4
  • [10] ACUTE EXACERBATIONS OF IDIOPATHIC PULMONARY FIBROSIS: BARRIER TO TRANSPLANT?
    Sayad, Karen
    Warrior, Krishnan
    O'Hara, Christopher
    Dilling, Daniel
    CHEST, 2021, 160 (04) : 2497A - 2498A